Skip to main content
. 2020 Oct 29;21(1):128. doi: 10.1186/s10194-020-01195-2

Fig. 1.

Fig. 1

Botulinum toxin A (BTX) treatment in Denmark (white) and Norway (black) during the lockdown. Respondents replied to the question “Did your Department continue botulinum toxin treatment for chronic migraine during the pandemic?”